Filing Details

Accession Number:
0001104659-11-052103
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-16 16:09:58
Reporting Period:
2011-09-15
Filing Date:
2011-09-16
Accepted Time:
2011-09-16 16:09:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp "CELG" Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421616 Graham Burton C/O Celgene Corporation
86 Morris Avenue
Summit NJ 07901
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-09-15 5,000 $60.76 48,033 No 4 S Direct
Common Stock Acquisiton 2011-09-15 2,000 $7.78 50,033 No 4 M Direct
Common Stock Disposition 2011-09-15 257 $60.33 49,776 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2011-09-15 2,000 $0.00 2,000 $7.78
Common Stock Employee Stock Option (right to buy) Acquisiton 2011-09-15 257 $0.00 257 $60.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,344 2013-07-03 No 4 M Direct
257 2012-03-15 2013-07-03 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,547 Indirect 401(k) Plan
Footnotes
  1. This transaction reflects the exercise of options resulting in the acquisition of 1,743 shares. No shares were sold in the open market.
  2. The option was fully exercisable.
  3. The option was issued pursuant to the Company's 2008 Stock Incentive Plan.